Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details Textual)

v3.3.1.900
Summary of Significant Accounting Policies (Details Textual) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Summary Of Significant Accounting Policies [Line Items]    
Property, Plant and Equipment, Depreciation Methods straight-line method  
Revenue from Grants $ 0 $ 579,079
Grants Receivable, Current 0 132,227
Research And Development Expense Including Grants 643,421  
Cash, FDIC Insured Amount 250,000  
Inventory Valuation Reserves $ 4,274 $ 40,703
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2,846,325 2,932,155
Previously Estimated Development Costs Incurred $ 5,521,390 $ 2,983,648
Asset Impairment Charges, Total 199,546  
Allowance for Doubtful Accounts Receivable $ 24,775 $ 15,145
Sales Revenue, Net [Member]    
Summary Of Significant Accounting Policies [Line Items]    
Concentration Risk, Percentage 66.00% 76.00%
Trade Accounts Receivable [Member]    
Summary Of Significant Accounting Policies [Line Items]    
Concentration Risk, Percentage 66.00% 92.00%
Patents [Member]    
Summary Of Significant Accounting Policies [Line Items]    
Finite-Lived Intangible Assets, Amortization Method straight-line method  
Finite-Lived Intangible Asset, Useful Life 20 years